Immunocytochemically Detectable TGF-β Associated with Malignancy in Thyroid Epithelial Neoplasia

References

• Akhurst R. J, Fee F., Balmain A. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature 1988; 331: 363–365
   PubMed Web of Science ®Google Scholar
• Anzano M. A., Roberts A. B., De Larco J. E., Wakefield L. M., Assoian R. K., Roche N. S., Smith J, Lazarus J. E., Sporn M. B. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol. Cell Biol. 1985; 5: 242–247
   PubMed Web of Science ®Google Scholar
• Assoian R. K., Fleurdelys B. E., Stevenson H. C, Miller P. J., Madtes D. K., Raines E. W., Ross R., Sporn M. B. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad Sri. USA 1987; 84: 6020–6024
   PubMed Web of Science ®Google Scholar
• Barnard J. A., Beauchamp R. D., Coffey R. J., Moses H. L. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. USA 1989; 86: 1578–1582
   PubMed Web of Science ®Google Scholar
• Coffey R. J., Goustin A. S., Soderquist A. M., Shipley G. D., Wolfshohl J., Carpenter G., Moses H. L. Transforming growth factor α and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res. 1987; 47: 4590–4594
   PubMed Web of Science ®Google Scholar
• Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
   PubMed Web of Science ®Google Scholar
• Derynck R., Goeddel D. V., Ullrich A., Gutterman J. U., Williams R. D., Bringman T. S., Berger W. H. Synthesis of messenger RNAs for transforming growth factors a and β and the epidermal growth factor receptor by human tumours. Cancer Res. 1987; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Fusco A., Grieco M., Santoro M., Berlingieri M. T., Piloti S., Pierotti M. A., Delia Porta G., Vecchio G. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 1987; 328: 170–172
   PubMed Web of Science ®Google Scholar
• Flanders K. C, Thompson N. L., Cissel D. S., van Obberghen-Schilling E., Baker C, Kass M. E., Ellingsworth L. R., Roberts A. B., Sporn M. B. Transforming growth factor β1: histochemical localisation with antibodies to different epitopes. J. Cell. Biol. 1989; 108: 653–660
   PubMed Web of Science ®Google Scholar
• Gerdes J. An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery. Int. J Cancer 1985; 35: 169–171
   PubMed Web of Science ®Google Scholar
• Hansen M. F., Cavenee W. K. Tumour suppressors: recessive mutations that lead to cancer. Cell 1988; 53: 172–173
   Web of Science ®Google Scholar
• Hedinger C., Williams E. D., Sobin L. H. Histological typing of thyroid tumours. Springer-Verlag, London. 1988
   Google Scholar
• Heine U. I., Munoz E. F., Flanders K, Ellingsworth L. R., Lam H-Y. P., Thompson N. L., Roberts A. B., Sporn M. B. Role of transforming growth factor-β in the development of the mouse embryo. J. Cell. Biol. 1987; 105: 2861–2876
   PubMed Web of Science ®Google Scholar
• Horowitz J. M., Yandell D., Park S-H., Buchkovich K., Whyte P., Harlow E., Weinberg R. A., Dryja T. P. Functional inactivation of the retinoblastoma anti-oncogene. Proceedings of Oncogenes and Growth Control. EMBL, Heidelberg. 1988
   Google Scholar
• Houck J. C. Chalones. Elsevier, New York 1976
   Google Scholar
• Kehrl J H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor p by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 1986; 163: 1037–1050
   PubMed Web of Science ®Google Scholar
• Kimchi A., Wang X-F., Weinberg R. A., Cheifetz S., Massague J. Absence of TGF-P receptors and growth inhibiting responses in retinoblastoma cells. Science 1988; 240: 196–199
   PubMed Web of Science ®Google Scholar
• Lee E., To H.Y-H., Shew J. Y., Bookstein R., Scully P., Lee W-H. lnactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218–221
   PubMed Web of Science ®Google Scholar
• Lemoine N. R., Mayall E. S., Wyllie F. S., Williams E. D., Goyns M., Stringer B., Wynford-Thomas D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989; 4: 159–164
   PubMed Web of Science ®Google Scholar
• Masui T., Wakefield L. M., Lechner J. F., LaVeck M. A., Sporn M. B., Harris C. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 1986; 83: 2438–2442
   PubMed Web of Science ®Google Scholar
• Miyazono K., Heldin C-H. Role for carbohydrate structures in TGF-β1 latency. Nature 1989; 338: 158–160
   PubMed Web of Science ®Google Scholar
• Miyazono K., Hellman U., Wernstedt C., Heldin C-H. Latent high molecular weight complex of transforming growth factor β1. J. Biol. Chem. 1988; 263: 6407–6415
   PubMed Web of Science ®Google Scholar
• Morris J. C., Ranganathan G., Hay I. D., Nelson R. E., Jiang N-S. The effects of transforming growth factor-β on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 1988; 123: 1385–1394
   PubMed Web of Science ®Google Scholar
• Newman G. R., Jasani B., Williams E. D. The visualisation of trace amounts of diaminobenzidine (DAB) polymer by a novel gold sulphide-silver method. J. Microsc 1983; 132: RP1–RP2
   Google Scholar
• Pircher R., Lawrence D. A., Jullien P. Latent β-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res. 1984; 44: 5538–5543
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B. Transforming growth factor β. Adv. Cancer Res. 1988; 51: 107–145
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Anzano M. A., Lamb L. C, Smith J M., Sporn M. B. New class of transforming growth factors potentiated by epidermal growth factor: isolation from nonneoplastic tissues. Proc. Natl. Acad. Sci. USA 1981; 78: 5339–5343
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Thompson N. L., Heine U., Flanders C., Sporn M. B. Transforming growth factor β: possible roles in carcinogenesis. Br. J. Cancer 1988; 57: 594–600
   PubMed Web of Science ®Google Scholar
• Shipley G. D., Pittelkow M. R., Wille J, Scott R. E., Moses H. L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 1986; 46: 2068–2071
   PubMed Web of Science ®Google Scholar
• Takehara K., Carwile LeRoy E., Grotendoret G. R. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth regulatory (competence) gene expression. Cell 1987; 149: 415–422
   Google Scholar
• T'ang A., Varley J. M., Chakraborty S., Murphree A. L.T., Fung Y-K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242: 263–266
   PubMed Web of Science ®Google Scholar
• Thompson N. L., Flanders K, Smith J. M., Ellingsworth L. R., Roberts A. B., Sporn M. B. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell. Biol. 1989; 108: 661–669
   PubMed Web of Science ®Google Scholar
• Tsushima T., Arai M., Saji M., Ohba Y., Murakami H., Ohmura E., Sato K., Shizume K. Effects of transforming growth factor-β on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 1988; 123: 1187–1194
   PubMed Web of Science ®Google Scholar
• Wakefield L. M., Smith D. periodic., Flanders K. C., Sporn M. B. Latent transforming growth factor-β from human platelets. J. Biol. Chem. 1988; 263: 7646–7654
   PubMed Web of Science ®Google Scholar